secwatch / observer

Ascend Wellness Holdings, Inc. — fact timeline

Source-grounded facts extracted from Ascend Wellness Holdings, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.

AAWH Ascend Wellness Holdings, Inc. JSON
Earnings Releases

Ascend Wellness Holdings, Inc. reported the quarter ended March 31, 2026 results: revenue $116.9 million.

“expressly incorporated by specific reference in such filing. --- EX-99.1 (EX-99.1) --- AWH Reports First Quarter 2026 Financial Results Generated Q1 2026 net revenue of $116.9 million and Adjusted EBITDA 1 of $26.3 million 51-location footprint to date, with five dispensaries added in 2026 2 Ranked No. 2 brand house in Illinois, Massachusetts, and New Jersey”
Shareholder Votes

Ascend Wellness Holdings, Inc. shareholders approved Reapproval of the Company’s stock incentive plan and approval of unallocated stock option entitlements thereunder at the 2026-04-29 meeting.

“Proposal 3: Reapproval of Stock Incentive Plan The reapproval of the Company’s stock incentive plan and the approval of unallocated stock option entitlements thereunder was approved based on the following votes:”
Shareholder Votes

Ascend Wellness Holdings, Inc. shareholders approved Ratification of appointment of WithumSmith+Brown, PC as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-04-29 meeting.

“Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of WithumSmith+Brown, PC to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified based on the following votes:”
Shareholder Votes

Ascend Wellness Holdings, Inc. shareholders approved Election of six directors to serve until the 2027 Annual Meeting at the 2026-04-29 meeting.

“Proposal 1: Election of Directors Each of the six nominees, each of whom was named in the Proxy Statement and unanimously recommended by the Board, was elected to serve on the Board to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is duly elected and qualified, based on the following votes:”
Governance Changes

Ascend Wellness Holdings, Inc.: Certificate of Retirement filed to reduce authorized shares of common stock and Class B common stock following conversion of all Class B shares (effective 2026-05-05).

“On May 5, 2026, the Company filed a Certificate of Retirement with the Secretary of State of the State of Delaware (the “Certificate of Retirement”) to effect the retirement of the 65,000 shares of Class B Common Stock that were issued but no longer outstanding following the Conversion. Pursuant to Section 243(b) of the DGCL, upon its effectiveness, the Certificate of Retirement had the effect of amending the Certificate of Incorporation to reduce the total number of authorized shares of common stock of the Company by 65,000, to 750,035,000, and to reduce the number of authorized shares of Class B Common Stock by 65,000, to 35,000.”
Earnings Releases

Ascend Wellness Holdings, Inc. reported FY 2025 results: revenue $500.6 million, net income $118.2 million.

“Total net revenue was $500.6 million compared to $561.6 million in full year 2024 (“FY 2024”).”
Earnings Releases

Ascend Wellness Holdings, Inc. reported Q4 2025 results: revenue $120.5 million, net income $48.7 million.

“Total net revenue was $120.5 million compared to $124.7 million in the third quarter of 2025 (“Q3 2025”).”
Auditor Changes

Ascend Wellness Holdings, Inc. engaged WithumSmith+Brown, PC as its auditor.

“On March 19, 2025, the Audit Committee approved the appointment of WithumSmith+Brown, PC (“Withum”) as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2025, effective immediately, and such approval was ratified by the Board.”
Auditor Changes

Ascend Wellness Holdings, Inc. dismissed Macias Gini & O'Connell LLP as its auditor.

“On March 20, 2025, Ascend Wellness Holdings, Inc. (the “Company”) notified Macias Gini & O’Connell LLP (“MGO”) that it was being dismissed as the Company’s independent registered public accounting firm effective March 19, 2025.”

Samuel Brill was removed as Lead Independent Director at Ascend Wellness Holdings, Inc..

“the Board appointed Samuel Brill as Chief Executive Officer of the Company and removed him as Lead Independent Director of the Board”

Samuel Brill was appointed as Chief Executive Officer at Ascend Wellness Holdings, Inc..

“the Board appointed Samuel Brill as Chief Executive Officer of the Company and removed him as Lead Independent Director of the Board, while maintaining his appointment as director of the Company, effective immediately.”

John Hartmann departed as Chief Executive Officer at Ascend Wellness Holdings, Inc..

“John Hartmann no longer serves as Chief Executive Officer of the Company.”

Julie Francis was appointed as Director at Ascend Wellness Holdings, Inc..

“On May 31, 2024, the board of directors (the “Board”) of Ascend Wellness Holdings, Inc. (the “Company”), upon recommendation of the Compensation and Corporate Governance Committee of the Board, appointed Julie Francis as a director of the Company, effective June 3, 2024”
Earnings Releases

Ascend Wellness Holdings, Inc. reported Q1 2024 (three months ended March 31, 2024) results: revenue $142.4 million, net income Net loss of $18.2 million.

“Q1 2024 Financial Highlights • Gross revenue increased 23.4% year-over-year and 0.6% quarter-over-quarter to $174.2 million. • Net revenue, which excludes intercompany sales of wholesale products, increased 24.7% year-over-year and 1.6% quarter-over-quarter to $142.4 million. • Retail revenue increased 15.1% year-over-year and decreased 2.2% quarter-over-quarter to $95.2 million. • Gross wholesale revenue increased 35.2% year-over-year and 4.2% quarter-over-quarter to $79.0 million. Wholesale revenue, net of intercompany sales, increased 50.2% year-over-year and 10.2% quarter-over-quarter to $47.2 million. • Net loss of $18.2 million during the quarter compared to $18.5 million in Q1 2023.”
Shareholder Votes

Ascend Wellness Holdings, Inc. shareholders approved Ratification of appointment of Macias Gini & O'Connell LLP as independent registered public accounting firm for fiscal year ending December 31, 2024 at the 2024-05-03 meeting.

“Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Macias Gini & O'Connell LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified based on the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES 150,256,263 80,511 29,494 298,607”
Shareholder Votes

Ascend Wellness Holdings, Inc. shareholders approved Election of six directors to serve until 2025 Annual Meeting at the 2024-05-03 meeting.

“Proposal 1: Election of Directors The following six (6) nominees, unanimously recommended by the Board, each of whom were named in the Proxy Statement, were elected to serve on the Board to hold office until the 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified, based on the following votes: Directors FOR WITHHELD BROKER NON-VOTES Abner Kurtin 88,412,388 7,340,416 54,831,560 John Hartmann 91,925,067 3,827,737 54,831,560 Samuel Brill 88,837,778 6,915,026 54,831,560 Scott Swid 95,341,862 410,942 54,831,560 Josh Gold 91,604,488 4,148,316 54,831,560 Francis Perullo 91,654,840 4,097,964 54,831,560”
Earnings Releases

Ascend Wellness Holdings, Inc. reported FY2023 results: net income $48.2 million loss.

“FY 2023: Net revenue increased 27.8% year-over year to $518.6 million.”
Earnings Releases

Ascend Wellness Holdings, Inc. reported Q4 FY2023 results: net income $19.3 million loss.

“Q4 2023: Net revenue, which excludes intercompany sale of wholesale products, decreased 0.8% quarter-over-quarter to $140.2 million, and increased 25.0% year-over year.”
Earnings Releases

Ascend Wellness Holdings, Inc. reported quarter ended September 30, 2023 results: revenue $141.3 million, net income Net loss of $11.2 million.

“Q3 2023 Financial Highlights • Gross revenue increased 26.6% year-over-year and 12.5% quarter-over-quarter to $169.9 million. • Net revenue, which excludes intercompany sales of wholesale products, increased 27.0% year-over-year and 14.9% quarter-over-quarter to $141.3 million. • Retail revenue increased 22.3% year-over-year and 12.7% quarter-over-quarter to $101.3 million. • Gross wholesale revenue increased 33.4% year-over-year and 12.2% quarter-over-quarter to $68.7 million. Wholesale revenue, net of intercompany sales, increased 40.6% year-over-year and 20.7% quarter-over-quarter to $40.0 million. • Net loss of $11.2 million during the quarter represented an improvement compared to $16.9 million in Q3 2022. • Adjusted EBITDA 2 was $29.5 million, representing a 20.9% margin. Adjusted EBITDA improved 38.5% and Adjusted EBITDA margin improved by 356 basis points quarter-over-quarter. Adjusted EBITDA increased 6% and margins declined 406 basis points year-over-year. • As of September 3”
Earnings Releases

Ascend Wellness Holdings, Inc. reported the quarter ended September 30, 2023 results: revenue net revenue up nearly 15% Q/Q to approximately $140 million.

“strong preliminary third quarter 2023 financial results as well as updates to its leadership team. • Record revenue for the 6th consecutive quarter, with net revenue up nearly 15% Q/Q to approximately $140 million; • Significant sequential Adjusted EBITDA 1 growth ranging from $27 to $29 million; and • Third consecutive quarter of positive Cash from”

Dan Neville departed as Chief Financial Officer at Ascend Wellness Holdings, Inc..

“On October 25, 2023, the Company announced that Dan Neville, the Company’s Chief Financial Officer, will be leaving the Company effective November 10, 2023.”

Mark Cassebaum was appointed as Chief Financial Officer at Ascend Wellness Holdings, Inc..

“On October 25, 2023, the Company announced the appointment of Mark Cassebaum as the new chief financial officer of the Company, effective November 27, 2023.”
Earnings Releases

Ascend Wellness Holdings, Inc. reported Q2 2023 results: revenue $123.0 million, net income $0.8 million.

“quarter-over-quarter to $151.0 million. • Net revenue, which excludes intercompany sales of wholesale products, increased 26.1% year-over-year and 7.7% quarter-over-quarter to $123.0 million. • Retail revenue increased 18.9% year-over-year and 8.6% quarter-over-quarter to $89.9 million. • Gross wholesale revenue increased 45.3% year-over-year and 4.7%”
Earnings Releases

Ascend Wellness Holdings, Inc. reported the quarter ended March 31, 2023 results: revenue $114.2 million, net income Net loss of $18.5 million.

“quarter-over-quarter to $141.2 million. • Net revenue, which excludes intercompany sale of wholesale products, increased 34.2% year-over-year and 1.9% quarter-over-quarter to $114.2 million. • Retail revenue increased 30.7% year-over-year but decreased 1.8% quarter-over-quarter to $82.7 million. • Gross wholesale revenue increased 54.0% year-over-year and 16.3%”
Shareholder Votes

Ascend Wellness Holdings, Inc. shareholders approved Approval of amendment to the Company’s 2021 Stock Incentive Plan at the 2023-05-05 meeting.

“Proposal 3: Approval of the amendment to the Company’s 2021 Stock Incentive Plan The amendment to the Company’s 2021 Stock Incentive Plan was approved based on the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES 74,384,528 50,282,769 1,120,445 42,265,515”
Shareholder Votes

Ascend Wellness Holdings, Inc. shareholders approved Ratification of appointment of Macias Gini & O'Connell LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-05-05 meeting.

“Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm for 2023 The appointment of Macias Gini & O'Connell LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified based on the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES 167,968,667 10,437 74,153 0”
Shareholder Votes

Ascend Wellness Holdings, Inc. shareholders approved Election of five directors to serve until the 2024 Annual Meeting at the 2023-05-05 meeting.

“Proposal 1: Election of Directors The following five (5) nominees, unanimously recommended by the Board, each of whom were named in the Proxy Statement, were elected to serve on the Board to hold office until the 2024 Annual Meeting of Stockholders or until their successors are duly elected and qualified, based on the following votes: Directors FOR WITHHELD BROKER NON-VOTES Abner Kurtin 72,166,242 53,621,500 42,265,515 Francis Perullo 75,550,262 50,237,480 42,265,515 Daniel Neville 71,154,596 54,633,146 42,265,515 Scott Swid 71,205,646 54,582,096 42,265,515 Josh Gold 125,693,415 94,327 42,265,515”

Frank Perullo changed role as Strategic Advisor at Ascend Wellness Holdings, Inc..

“Frank Perullo, a co-founder of the Company, who currently serves as a director, President and Interim Co-Chief Executive Officer of the Company, will continue to serve on the Board, and will transition to a Strategic Advisor role for the Company, focusing on regulatory issues and legalization efforts, effective May 15, 2023.”

John Hartmann was appointed as director at Ascend Wellness Holdings, Inc..

“the Board also appointed Mr. Hartmann as a director of the Company, effective May 15, 2023.”

John Hartmann was appointed as Chief Executive Officer at Ascend Wellness Holdings, Inc..

“On May 9, 2023, the Company’s board of directors (the “Board”) approved the appointment of John Hartmann as the new chief executive officer of the Company, effective May 15, 2023.”

Emily Paxhia resigned as member of the Board at Ascend Wellness Holdings, Inc..

“Emily Paxhia informed the Company that she will be resigning as a member of the Board effective upon the earlier of December 1, 2022 and the appointment of a new independent director to the Board.”

Joshua Gold was appointed as independent director at Ascend Wellness Holdings, Inc..

“the Company appointed Joshua Gold as an independent director”

Abner Kurtin changed role as Executive Chairman at Ascend Wellness Holdings, Inc..

“Chairman, Founder and former-CEO Abner Kurtin will transition to the role of Executive Chairman of the Board.”

Daniel Neville was appointed as Interim Co-CEO at Ascend Wellness Holdings, Inc..

“President & Co-founder Frank Perullo and Chief Financial Officer Daniel Neville had been appointed Interim Co-CEOs, effective as of September 27, 2022.”

Frank Perullo was appointed as Interim Co-CEO at Ascend Wellness Holdings, Inc..

“President & Co-founder Frank Perullo and Chief Financial Officer Daniel Neville had been appointed Interim Co-CEOs, effective as of September 27, 2022.”

Joseph Hinrichs resigned as Director at Ascend Wellness Holdings, Inc..

“On September 14, 2022 Joseph Hinrichs informed Ascend Wellness Holdings, Inc. (the “Company”) that he will resign from the Board of Directors of the Company (the “Board”) and the Board’s the Audit Committee and Compensation and Corporate Governance Committee, effective immediately.”

Abner Kurtin changed role as President at Ascend Wellness Holdings, Inc..

“Effective February 11, 2022, Mr. Kurtin will no longer serve as President of the Company but will continue to serve as the Company’s Chief Executive Officer and Chairman of the Board.”

Frank Perullo changed role as President at Ascend Wellness Holdings, Inc..

“On February 14, 2022, Ascend Wellness Holdings, Inc. (the “Company”) announced it promoted the Company's co-founder and Chief Strategy Officer, Frank Perullo, to President of the Company.”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.